Westchester Capital Management, Inc. Viatris Inc Transaction History

Westchester Capital Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $294 - $392	-32 Reduced 22.38%	111 $1,000
Q4 2022 Feb 08, 2023	SELL	$8.72 - $11.56 $113 - $150	-13 Reduced 8.33%	143 $1,000
Q3 2022 Nov 09, 2022	SELL	$8.48 - $11.13 $165,996 - $217,869	-19,575 Reduced 99.21%	156 $1,000
Q2 2022 Aug 09, 2022	SELL	$9.95 - $12.27 $228 - $282	-23 Reduced 0.12%	19,731 $207,000
Q1 2022 May 10, 2022	SELL	$9.81 - $15.4 $1,795 - $2,818	-183 Reduced 0.92%	19,754 $215,000
Q4 2021 Feb 09, 2022	SELL	$12.09 - $14.68 $76,287 - $92,630	-6,310 Reduced 24.04%	19,937 $270,000
Q3 2021 Nov 10, 2021	SELL	$13.25 - $15.13 $68,608 - $78,343	-5,178 Reduced 16.48%	26,247 $356,000
Q2 2021 Aug 04, 2021	SELL	$12.97 - $16.15 $31,179 - $38,824	-2,404 Reduced 7.11%	31,425 $449,000
Q1 2021 May 07, 2021	SELL	$13.59 - $18.54 $3,519 - $4,801	-259 Reduced 0.76%	33,829 $473,000
Q4 2020 Feb 08, 2021	BUY	$14.3 - $18.74 $487,458 - $638,809	34,088 New	34,088 $639,000

1,091

966M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Westchester Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Westchester Capital Management, Inc. with notifications on news.